Product Images Amoxicillin

Each tablet of this medication contains 875 mg of amoxicillin trihydrate, which is an antibiotic. The usual dosage is one tablet every 12 hours. Manufacturer's information with prescribing details and storage instructions can be found in an accompanying document. The tablets should be kept at a temperature of 20 to 25°C, protected from light and moisture, and stored in a tight, light-resistant container with a child-resistant closure. Expiration date is 08/2023 and the batch number is 299799. This medication is manufactured by an unidentified company in Jordan and packaged by PD-Rx Pharmaceuticals in Oklahoma City.*

This is a dosing recommendation table for adult and pediatric patients over three months old for infections in various body parts caused by susceptible bacteria. The dosing varies based on the severity of the infection and the age of the patient. The table also provides dosage details for acute, uncomplicated ano-genital and urethral infections in men and women. The recommendations caution against using probenecid in children under two years old. The advice for children under 40 kg and over 40 kg is also provided.*

This is a table showing the pharmacokinetic parameters of Amoxicillin in healthy adults who were administered 400 mg/5 mL suspension or 400 mg chewable tablets at the start of a light meal. The table includes the mean values of 24 normal volunteers and shows the AUC and peak concentrations of Amoxicillin at the specified doses.*

This is a list of different types of bacteria categorized into two groups: Gram-Positive Bacteria and Gram-Negative Bacteria. The names of the bacteria within each group are further listed which include Enterococcus faecalis, Staphylococcus spp., Streptococcus pneumoniae, and alpha and beta-hemolytic streptococci for Gram-Positive Bacteria and Escherichia coli, Haemophilus influenzae, Neisseria gonorrhoeae, Proteus mirabilis, and Helicobacter pylori for Gram-Negative Bacteria.*

This is a table presenting the results of two studies examining the efficacy of triple therapy containing amoxicillin, in eradicating H. pylori infection in patients with confirmed duodenal ulcers. The analysis included both evaluable and intent-to-treat patient groups, and the results are presented with a 95% confidence interval. Inclusion criteria for patients included confirmed H. pylori infection and a documented active or recently resolved duodenal ulcer. Patients who dropped out due to adverse effects were included in the analysis as therapy failures.*

Not available. The text seems to be incomplete and contains errors in formatting and spelling, making it difficult to understand.*